Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that the...
TriLink BioTechnologies Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea
TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids...
Clarity and Evergreen enter Targeted Copper Theranostics manufacturing agreement for US clinical trials
Clarity Pharmaceuticals, an Australian-based clinical stage radiopharmaceutical company developing next-generation products to address the growing...
Merck Licenses Foundational CRISPR Technology to Cellecta, Paving Path for Development of Next-Generation Treatments
Merck, a leading science and technology company, announced that its Life Science business sector has...
Phesi Big Data Analysis of Over 200,000 Hepatitis B and C Patients Identifies Typical...
Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, has analyzed...
Sanofi to focus its COVID-19 development efforts on the recombinant vaccine candidate
Recent positive interim results of Sanofi’s mRNA-based COVID-19 vaccine candidate Phase 1/2 study confirm the...
Syndax and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host...
Syndax Pharmaceuticals, Inc. and Incyte announced that they have entered into an exclusive worldwide collaboration...
Union therapeutics signs deal with Innovent to develop orismilast in China
Union therapeutics has signed a strategic partnership and license agreement with Innovent Biologics to develop...
InSilicoTrials and Galileo Research announce their partnership
Innovation and cutting-edge technology to reduce Research and Development time and costs: InSilicoTrials, a company...
Velocity Clinical Research’s multi-site acquisitions signal new frontier for clinical site management industry
Velocity Clinical Research announces it has acquired two multi-site companies, VitaLink Research and the National...
